Ethical oversight in quality improvement and quality improvement research: new approaches to promote a learning health care system. Fiscella, K., Tobin, J., N., Carroll, J., K., He, H., & Ogedegbe, G. BMC medical ethics, 16(1):62-63, 9, 2015.
abstract   bibtex   
BACKGROUND: Institutional review boards (IRBs) distinguish health care quality improvement (QI) and health care quality improvement research (QIR) based primarily on the rigor of the methods used and the purported generalizability of the knowledge gained. Neither of these criteria holds up upon scrutiny. Rather, this apparently false dichotomy may foster under-protection of participants in QI projects and over-protection of participants within QIR. DISCUSSION: Minimal risk projects should entail minimal oversight including waivers for informed consent for both QI and QIR projects. Minimizing the burdens of conducting QIR, while ensuring minimal safeguards for QI projects, is needed to restore this imbalance in oversight. Potentially, such ethical oversight could be provided by the integration of Institutional Review Boards and Clinical Ethical Committees, using a more integrated and streamlined approach such as a two-step process involving a screening review, followed by a review by committee trained in QIR. Standards for such ethical review and training in these standards, coupled with rapid review cycles, could facilitate an appropriate level of oversight within the context of creating and sustaining learning health care systems. We argue that QI and QIR are not reliably distinguishable. We advocate for approaches that improve protections for QI participants while minimizing over-protection for participants in QIR through reasonable ethical oversight that aligns risk to participants in both QI and QIR with the needs of a learning health care system.
@article{
 title = {Ethical oversight in quality improvement and quality improvement research: new approaches to promote a learning health care system},
 type = {article},
 year = {2015},
 identifiers = {[object Object]},
 pages = {62-63},
 volume = {16},
 month = {9},
 day = {17},
 city = {Department of Family Medicine, University of Rochester Medical Center, Rochester, USA. Kevin_fiscella@urmc.rochester.edu.; Family Medicine Research, 1381 South Ave, Rochester, NY, 14620, USA. Kevin_fiscella@urmc.rochester.edu.; Clinical Directors Network },
 id = {d28ccf46-1d95-3284-a0bb-b65689044d21},
 created = {2016-08-21T22:18:55.000Z},
 file_attached = {false},
 profile_id = {217ced55-4c79-38dc-838b-4b5ea8df5597},
 group_id = {408d37d9-5f1b-3398-a9f5-5c1a487116d4},
 last_modified = {2017-03-14T09:54:45.334Z},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {true},
 hidden = {false},
 source_type = {JOUR},
 notes = {LR: 20151001; GR: K24 HL111315/HL/NHLBI NIH HHS/United States; JID: 101088680; OID: NLM: PMC4574354; 2015/03/10 [received]; 2015/09/07 [accepted]; 2015/09/17 [aheadofprint]; epublish},
 folder_uuids = {c3aee5bd-652d-45ab-8a8e-22150c3add1e},
 private_publication = {false},
 abstract = {BACKGROUND: Institutional review boards (IRBs) distinguish health care quality improvement (QI) and health care quality improvement research (QIR) based primarily on the rigor of the methods used and the purported generalizability of the knowledge gained. Neither of these criteria holds up upon scrutiny. Rather, this apparently false dichotomy may foster under-protection of participants in QI projects and over-protection of participants within QIR. DISCUSSION: Minimal risk projects should entail minimal oversight including waivers for informed consent for both QI and QIR projects. Minimizing the burdens of conducting QIR, while ensuring minimal safeguards for QI projects, is needed to restore this imbalance in oversight. Potentially, such ethical oversight could be provided by the integration of Institutional Review Boards and Clinical Ethical Committees, using a more integrated and streamlined approach such as a two-step process involving a screening review, followed by a review by committee trained in QIR. Standards for such ethical review and training in these standards, coupled with rapid review cycles, could facilitate an appropriate level of oversight within the context of creating and sustaining learning health care systems. We argue that QI and QIR are not reliably distinguishable. We advocate for approaches that improve protections for QI participants while minimizing over-protection for participants in QIR through reasonable ethical oversight that aligns risk to participants in both QI and QIR with the needs of a learning health care system.},
 bibtype = {article},
 author = {Fiscella, K and Tobin, J N and Carroll, J K and He, H and Ogedegbe, G},
 journal = {BMC medical ethics},
 number = {1}
}

Downloads: 0